Intercept Pharmaceuticals, Inc. (ICPT) SEC filings
ICPT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ICPT overview →
6 measured ICPT SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G INTERCEPT PHARMACEUTICAL | SEC filing · Form 15-12G | — | — | |
| Form EFFECT INTERCEPT PHARMACEUTICAL | SEC filing · Form EFFECT | — | — | |
| Form 8-K INTERCEPT PHARMACEUTICAL For: Nov 08 | SEC filing · Form 8-K | — | — | |
| Form POS AM INTERCEPT PHARMACEUTICAL | SEC filing · Form POS | — | — | |
| Form S-8 POS INTERCEPT PHARMACEUTICAL | SEC filing · Form S-8 | — | — | |
| Form 10-Q INTERCEPT PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | -0.10% | +0.00% |
Keep exploring
More ICPT: earnings → · analyst actions → · ICPT overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PharmaCyte Biotech, Inc. (PMCB) | 84 | 0.00% | 41% |
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Ethos Technologies Inc. - Class A (LIFE) | 83 | -0.31% | 32% |
| COLOPLAST AS SP/ADR (CLPBY) | 82 | +0.13% | 59% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.